These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5106916)

  • 1. Quantitative aspects of the binding of folic acid by folate antiserum.
    Rothenberg SP; Gizis F
    Cancer Res; 1971 Aug; 31(8):1095-9. PubMed ID: 5106916
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies against folic acid. I. In vitro biophysical effect.
    Rothenberg SP; Gizis F; Kamen B
    J Lab Clin Med; 1969 Oct; 74(4):662-71. PubMed ID: 4186093
    [No Abstract]   [Full Text] [Related]  

  • 3. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.
    Lu Y; Low PS
    Cancer Immunol Immunother; 2002 May; 51(3):153-62. PubMed ID: 11941454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiserum to ceramide lactoside hapten mixed with carrier protein.
    Tal C; Taketomi T; Yamakawa T
    Isr J Med Sci; 1967; 3(4):577-80. PubMed ID: 6060574
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
    Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
    J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular aspects of folate and antifolate membrane transport.
    Brzezińska A; Wińska P; Balińska M
    Acta Biochim Pol; 2000; 47(3):735-49. PubMed ID: 11310973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stopped-flow kinetic studies of the interaction of bovine folate binding protein (FBP) and folate.
    Christensen U; Holm J; Hansen SI
    Biosci Rep; 2006 Aug; 26(4):291-9. PubMed ID: 17029005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
    [No Abstract]   [Full Text] [Related]  

  • 10. Affinity of radioiodinated bovine serum albumin for lymphoid cells. 3. Further experiments with cells of normal animals.
    Naor D; Sulitzeanu D
    Isr J Med Sci; 1970; 6(4):519-22. PubMed ID: 5472334
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-bovine serum albumin specificity and binding affinity after termination of tolerance to bovine serum albumin.
    Linscott WD; Weigle WO
    J Immunol; 1965 Sep; 95(3):546-58. PubMed ID: 5841047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic news--III. Folic coenzymes (folinic acid)].
    Minerva Med; 1984 May; 75(20):1247-54. PubMed ID: 6610137
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the folate coenzymes in cellular division. A review.
    O'BRIEN JS
    Cancer Res; 1962 Apr; 22():267-81. PubMed ID: 14480820
    [No Abstract]   [Full Text] [Related]  

  • 14. Inactivators of hapten-coupled bacteriophages in normal sera.
    Jormalainen S
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(6):747-53. PubMed ID: 5290404
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporation of radioactive folic acid into liver folate.
    Corrocher R; Bhuyan BK; Hoffbrand AV
    Br J Haematol; 1972 May; 22(5):637-8. PubMed ID: 5032107
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterophile antibodies and tissue injury. 1. Ultrastructure of pulmonary vascular lesions produced by Forssman antiserum in guinea-pigs.
    Taichman NS; Creighton M; Stephenson A; Tsai CC
    Immunology; 1972 Jan; 22(1):93-102. PubMed ID: 4536871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement and heterophile shock.
    Spear GS; Kihara I
    Johns Hopkins Med J; 1970 Apr; 126(4):210-6. PubMed ID: 5310147
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration.
    Jansen G; Barr H; Kathmann I; Bunni MA; Priest DG; Noordhuis P; Peters GJ; Assaraf YG
    Mol Pharmacol; 1999 Apr; 55(4):761-9. PubMed ID: 10101035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding of folates and antifolates to brush-border membrane vesicles isolated from human kidney.
    Damaraju VL; Hamilton KF; Seth-Smith ML; Cass CE; Sawyer MB
    Mol Pharmacol; 2005 Feb; 67(2):453-9. PubMed ID: 15509714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.